electroCore Inc. (ECOR)
electroCore Inc. (ECOR) Stock Price, Analysis & Data
| Bid | 7.46 |
| Market Cap | 97.46M |
| Revenue (ttm) | 36.97M |
| Net Income (ttm) | -14.77M |
| Beta | 0.94 |
| EPS (ttm) | -1.65 |
| PE Ratio (ttm) | n/a |
| Forward PE | -19.65 |
| P/B (ttm) | -34.87 |
| P/S (ttm) | 2.64 |
| Earnings Date | Nov 4, 2026 |
| Ask | 13.45 |
| Volume | 14,445 |
| Avg. Volume (20D) | 119,514 |
| Open | 10.35 |
| Previous Close | 10.27 |
| Day's Range | 9.85 - 10.66 |
| 52-Week Range | 4.41 - 10.68 |
| Analyst | Strong Buy |
| Price Target | 19.85 (88.51%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ECOR
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of ...
Financial Performance
In 2025, electroCore's revenue was 32.03M, an increase of 27.2% compared to the previous year's 25.18M. Earnings were -13.97M, an increase of 17.5%.
Financial StatementsAnalyst Forecast
According to 5 analyst ratings, the average rating for ECOR stock is "Strong Buy". The 12-month stock price forecast is 19.85, which is upside of 88.51% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
